Key facts
- Notable investors include Talok Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Billow AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Billow AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Billow AI
Developer of an AI-powered financial modeling and scenario analysis platform designed for biotech and life sciences financial workflows. The company's platform integrates directly with spreadsheet editors to automate valuation modeling, clinical trial budgeting, forecasting, benchmarking, assumption updates, scenario testing, M&A and proxy statement analysis, formula auditing, and generation of structured financial outputs, enabling biotech and life sciences finance teams to streamline model upkeep, reduce manual work, and make decisions with greater consistency and clarity.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2026
- Website
- thebillow.ai/
- Ownership
- Privately Held (backing)
Billow AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Billow AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Billow AI in its N-PORT filings yet. We sweep new filings monthly.